chartexchange

Sutro Biopharma to Participate in Upcoming Investor Conferences

GlobeNewswire Inc. | Nov 4, 2026 8:00 AM EST

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.

Read original article